CVS Group plc (LON:CVSG - Get Free Report) passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 1,112.26 ($14.69) and traded as high as GBX 1,248 ($16.49). CVS Group shares last traded at GBX 1,228 ($16.22), with a volume of 244,441 shares trading hands.
Analyst Ratings Changes
Separately, Berenberg Bank reiterated a "buy" rating and set a GBX 2,000 ($26.42) target price on shares of CVS Group in a report on Thursday, July 24th.
View Our Latest Analysis on CVSG
CVS Group Stock Down 2.6%
The firm's 50-day moving average price is GBX 1,243.08 and its 200-day moving average price is GBX 1,112.26. The company has a market cap of £857.21 million, a price-to-earnings ratio of 41.41, a price-to-earnings-growth ratio of 1.77 and a beta of 1.02. The company has a debt-to-equity ratio of 110.52, a current ratio of 1.09 and a quick ratio of 0.90.
Insiders Place Their Bets
In related news, insider Richard Fairman acquired 1,644 shares of CVS Group stock in a transaction on Friday, July 11th. The shares were bought at an average price of GBX 1,216 ($16.06) per share, for a total transaction of £19,991.04 ($26,408.24). Also, insider David Wilton bought 1,000 shares of the firm's stock in a transaction dated Monday, June 2nd. The stock was bought at an average cost of GBX 1,248 ($16.49) per share, with a total value of £12,480 ($16,486.13). 5.83% of the stock is currently owned by corporate insiders.
CVS Group Company Profile
(
Get Free Report)
CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CVS Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Group wasn't on the list.
While CVS Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.